The Absence of p53 Promotes Metastasis in a Novel Somatic Mouse Model for Hepatocellular Carcinoma

REFERENCES

• Abou-Elella, A., T. Gramlich, C. Fritsch, and T. Gansler. 1996. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis. Mod. Pathol. 9:95–98.
   PubMed Web of Science ®Google Scholar
• Baldi, P., and A. D. Long. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509–519.
   PubMed Web of Science ®Google Scholar
• Bates, P., J. A. Young, and H. E. Varmus. 1993. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 74:1043–1051.
   PubMed Web of Science ®Google Scholar
• Beasley, R. P. 1988. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942–1956.
   PubMed Web of Science ®Google Scholar
• Beer, S., A. Zetterberg, R. A. Ihrie, R. A. McTaggart, Q. Yang, N. Bradon, C. Arvanitis, L. D. Attardi, S. Feng, B. Ruebner, R. D. Cardiff, and D. W. Felsher. 2004. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol. 2:e332.
   PubMed Web of Science ®Google Scholar
• Bouchard, M. J., L. H. Wang, and R. J. Schneider. 2001. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294:2376–2378.
   PubMed Web of Science ®Google Scholar
• Buendia, M. A. 2000. Genetics of hepatocellular carcinoma. Semin. Cancer Biol. 10:185–200.
   PubMed Web of Science ®Google Scholar
• Deane, N. G., H. Lee, J. Hamaamen, A. Ruley, M. K. Washington, B. LaFleur, S. S. Thorgeirsson, R. Price, and R. D. Beauchamp. 2004. Enhanced tumor formation in cyclin D1 × transforming growth factor β1 double transgenic mice with characterization by magnetic resonance imaging. Cancer Res. 64:1315–1322.
   PubMedGoogle Scholar
• Deane, N. G., M. A. Parker, R. Aramandla, L. Diehl, W. J. Lee, M. K. Washington, L. B. Nanney, Y. Shyr, and R. D. Beauchamp. 2001. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res. 61:5389–5395.
   PubMed Web of Science ®Google Scholar
• Eferl, R., R. Ricci, L. Kenner, R. Zenz, J. P. David, M. Rath, and E. F. Wagner. 2003. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112:181–192.
   PubMed Web of Science ®Google Scholar
• Felsenstein, J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791.
   PubMed Web of Science ®Google Scholar
• Fults, D., C. Pedone, C. Dai, and E. C. Holland. 2002. MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo. Neoplasia 4:32–39.
   PubMedGoogle Scholar
• Gottlieb, K. A., and L. P. Villarreal. 2001. Natural biology of polyomavirus middle T antigen. Microbiol. Mol. Biol. Rev. 65:288–318.
   PubMedGoogle Scholar
• Harada, N., H. Oshima, M. Katoh, Y. Tamai, M. Oshima, and M. M. Taketo. 2004. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res. 64:48–54.
   PubMed Web of Science ®Google Scholar
• Himly, M., D. N. Foster, I. Bottoli, J. S. Iacovoni, and P. K. Vogt. 1998. The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248:295–304.
   PubMed Web of Science ®Google Scholar
• Holland, E. C., Y. Li, J. Celestino, C. Dai, L. Schaefer, R. A. Sawaya, and G. N. Fuller. 2000. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo. Am. J. Pathol. 157:1031–1037.
   PubMed Web of Science ®Google Scholar
• Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1–7.
   PubMed Web of Science ®Google Scholar
• Jhappan, C., C. Stahle, R. N. Harkins, N. Fausto, G. H. Smith, and G. T. Merlino. 1990. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137–1146.
   PubMed Web of Science ®Google Scholar
• Kemp, C. J., L. A. Donehower, A. Bradley, and A. Balmain. 1993. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74:813–822.
   PubMed Web of Science ®Google Scholar
• Lau, J. W. Y., and C. K. Leow. 1999. Surgical management, p. 147–172. In A. S.-Y. Leong, C. T. Liew, J. W. Y. Lau, and P. J. Johnson (ed.), Hepatocellular carcinoma: diagnosis, investigation and management. Arnold, London, England.
   Google Scholar
• Lehnert, S. A., and R. J. Akhurst. 1988. Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 104:263–273.
   PubMed Web of Science ®Google Scholar
• Leong, A. S.-Y. 1999. Epidemiology, risk factors, etiology, premalignant lesions and carcinogenesis, p. 1–18. In A. S.-Y. Leong, C. T. Liew, J. W. Y. Lau, and P. J. Johnson (ed.), Hepatocellular carcinoma: diagnosis, investigation and management. Arnold, London, England.
   Google Scholar
• Leong, A. S.-Y., and C. T. Liew. 1999. Needle biopsy diagnosis of hepatocellular carcinoma, p. 107–129. In A. S.-Y. Leong, C. T. Liew, J. W. Y. Lau, and P. J. Johnson (ed.), Hepatocellular carcinoma: diagnosis, investigation and management. Arnold, London, England.
   Google Scholar
• Leung, T. W. T. 1999. Non-surgical management, p. 173–191. In A. S.-Y. Leong, C. T. Liew, J. W. Y. Lau, and P. J. Johnson (ed.), Hepatocellular carcinoma: diagnosis, investigation and management. Arnold, London, England.
   Google Scholar
• Lewis, B. C., D. S. Klimstra, and H. E. Varmus. 2003. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev. 17:3127–3138.
   PubMed Web of Science ®Google Scholar
• Liew, C. T., H. M. Li, K. W. Lo, C. K. Leow, J. Y. Chan, L. Y. Hin, W. Y. Lau, P. B. Lai, B. K. Lim, J. Huang, W. T. Leung, S. Wu, and J. C. Lee. 1999. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene 18:789–795.
   PubMedGoogle Scholar
• Manickan, E., J. Satoi, T. C. Wang, and T. J. Liang. 2001. Conditional liver-specific expression of simian virus 40 T antigen leads to regulatable development of hepatic neoplasm in transgenic mice. J. Biol. Chem. 276:13989–13994.
   PubMedGoogle Scholar
• Matsuda, Y., T. Ichida, J. Matsuzawa, K. Sugimura, and H. Asakura. 1999. p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116:394–400.
   PubMedGoogle Scholar
• Matsuo, K., I. Kobayashi, T. Tsukuba, T. Kiyoshima, Y. Ishibashi, A. Miyoshi, K. Yamamoto, and H. Sakai. 1996. Immunohistochemical localization of cathepsins D and E in human gastric cancer: a possible correlation with local invasive and metastatic activities of carcinoma cells. Hum. Pathol. 27:184–190.
   PubMedGoogle Scholar
• Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239–4242.
   PubMed Web of Science ®Google Scholar
• Murakami, H., N. D. Sanderson, P. Nagy, P. A. Marino, G. Merlino, and S. S. Thorgeirsson. 1993. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. 53:1719–1723.
   PubMed Web of Science ®Google Scholar
• Nishida, N., Y. Fukuda, T. Komeda, R. Kita, T. Sando, M. Furukawa, M. Amenomori, I. Shibagaki, K. Nakao, M. Ikenaga, et al. 1994. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54:3107–3110.
   PubMed Web of Science ®Google Scholar
• Ong, S. H., S. Dilworth, I. Hauck-Schmalenberger, T. Pawson, and F. Kiefer. 2001. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. EMBO J. 20:6327–6336.
   PubMedGoogle Scholar
• Orsulic, S. 2002. An RCAS-TVA-based approach to designer mouse models. Mamm. Genome 13:543–547.
   PubMedGoogle Scholar
• Orsulic, S., Y. Li, R. A. Soslow, L. A. Vitale-Cross, S. J. Gutkind, and H. E. Varmus. 2002. Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1:53–62.
   PubMed Web of Science ®Google Scholar
• Parkin, D. M. 2001. Global cancer statistics in the year 2000. Lancet Oncol. 2:533–543.
   PubMed Web of Science ®Google Scholar
• Pereira, J. J., T. Meyer, S. E. Docherty, H. H. Reid, J. Marshall, E. W. Thompson, J. Rossjohn, and J. T. Price. 2004. Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with αβ3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res. 64:977–984.
   PubMedGoogle Scholar
• Pinkert, C. A., D. M. Ornitz, R. L. Brinster, and R. D. Palmiter. 1987. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1:268–276.
   PubMed Web of Science ®Google Scholar
• Robinson, W. S. 1994. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annu. Rev. Med. 45:297–323.
   PubMedGoogle Scholar
• Roe, T., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099–2108.
   PubMed Web of Science ®Google Scholar
• Sachdev, D., J. S. Hartell, A. V. Lee, X. Zhang, and D. Yee. 2004. A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J. Biol. Chem. 279:5017–5024.
   PubMed Web of Science ®Google Scholar
• Sandgren, E. P., C. J. Quaife, C. A. Pinkert, R. D. Palmiter, and R. L. Brinster. 1989. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4:715–724.
   PubMed Web of Science ®Google Scholar
• Schaefer-Klein, J., I. Givol, E. V. Barsov, J. M. Whitcomb, M. VanBrocklin, D. N. Foster, M. J. Federspiel, and S. H. Hughes. 1998. The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 248:305–311.
   PubMedGoogle Scholar
• Shachaf, C. M., A. M. Kopelman, C. Arvanitis, A. Karlsson, S. Beer, S. Mandl, M. H. Bachmann, A. D. Borowsky, B. Ruebner, R. D. Cardiff, Q. Yang, J. M. Bishop, C. H. Contag, and D. W. Felsher. 2004. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431:1112–1117.
   PubMed Web of Science ®Google Scholar
• Simonetti, R. G., M. Cottone, A. Craxi, L. Pagliaro, M. Rapicetta, P. Chionne, and A. Costantino. 1989. Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 2:1338.
   PubMedGoogle Scholar
• Soukas, A., P. Cohen, N. D. Socci, and J. M. Friedman. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 14:963–980.
   PubMed Web of Science ®Google Scholar
• Terradillos, O., O. Billet, C. A. Renard, R. Levy, T. Molina, P. Briand, and M. A. Buendia. 1997. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14:395–404.
   PubMed Web of Science ®Google Scholar
• Wang, R., L. D. Ferrell, S. Faouzi, J. J. Maher, and J. M. Bishop. 2001. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J. Cell Biol. 153:1023–1034.
   PubMed Web of Science ®Google Scholar
• Weiss, R. 1982. Experimental biology and assay of RNA tumor viruses, p. 209–260. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses, vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Wilkinson, D. G., J. A. Bailes, and A. P. McMahon. 1987. Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell 50:79–88.
   PubMed Web of Science ®Google Scholar
• Young, J. A., P. Bates, and H. E. Varmus. 1993. Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J. Virol. 67:1811–1816.
   PubMedGoogle Scholar
• Zhang, D., A. A. Samani, and P. Brodt. 2003. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm. Metab. Res. 35:802–808.
   PubMed Web of Science ®Google Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2433.
   PubMed Web of Science ®Google Scholar